http://medicalxpress.com/ en-us Medical Xpress internet news portal provides the latest news on Health and Medicine. (HealthDay)—The Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast Implant has been approved by the U.S. Food and Drug Administration for breast augmentation in women aged 22 years or older and for reconstruction in women of all ages. http://medicalxpress.com/news/2013-02-fda-silicone-gel-filled-breast-implant.html Other Thu, 21 Feb 2013 13:10:01 EST news280673729 A University of Colorado Cancer Center review published this week in the journal Lancet Oncology describes possible long-term side-effects of new, targeted therapies in pediatric cancer patients: what we don't know may hurt us. http://medicalxpress.com/news/2013-02-long-term-side-effects-therapies-pediatric-cancer.html Cancer Thu, 07 Feb 2013 12:02:02 EST news279460915 A multi-center study supports the effectiveness of the newest technology available for the treatment of difficult, life-threatening brain aneurysms. The technology, the Pipeline embolization device, is a flow diverter that redirects blood flow away from wide-necked or giant aneurysms that cannot be treated in more conventional ways. http://medicalxpress.com/news/2013-01-flow-diverting-device-aneurysms.html Neuroscience Wed, 30 Jan 2013 13:19:32 EST news278774364 (HealthDay)—A U.S. Food and Drug Administration advisory committee on Thursday recommended against approval of the first proposed drug to treat chronic fatigue syndrome. http://medicalxpress.com/news/2012-12-fda-panel-1st-drug-chronic_1.html Medications Fri, 21 Dec 2012 10:40:42 EST news275308835 The rugged, low-cost wheelchairs designed by SF State's Whirlwind Wheelchair program have helped thousands of people in developing countries. Now they're available in the U.S., where they are opening up new territory for American wheelchair-riders, from hiking trails and beaches to snow-covered ground. http://medicalxpress.com/news/2012-12-off-road-wheelchairs.html Health Fri, 14 Dec 2012 08:39:46 EST news274696748 A new technology called the Pipeline embolization device (PED) shows encouraging results in patients with certain types of difficult-to-treat brain aneurysms, reports the December issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. http://medicalxpress.com/news/2012-12-pipeline-device-option-difficult-to-treat-aneurysms.html Surgery Mon, 03 Dec 2012 12:48:20 EST news273761284 The Feinstein Institute for Medical Research announced today the submission of a New Drug Application to the US Food and Drug Administration (FDA) for the Fluorodopa F 18 positron emission tomography (PET) scan used to diagnose parkinsonian syndromes. Earlier this year, the Feinstein Institute received FDA approval under an Expanded Access Investigational New Drug (IND) program, permitting the Feinstein Institute to receive reimbursement for the use of the diagnostic tool in clinical research studies. This was the first time the FDA approved payment for Fluorodopa F 18 PET studies in parkinsonian syndromes. http://medicalxpress.com/news/2012-11-feinstein-submission-drug-application-parkinsonian.html Parkinson's & Movement disorders Wed, 14 Nov 2012 12:57:34 EST news272120187 A drug originally developed to prevent the rejection of transplanted organs has now been shown to dramatically reduce a particular kind of brain tumor in patients with tuberous sclerosis complex (TSC)—a genetic disease that causes tumors to grow on vital organs. http://medicalxpress.com/news/2012-11-drug-brain-tumors-children-tuberous.html Cancer Tue, 13 Nov 2012 18:30:04 EST news272046793 Nisin, a common food preservative, may slow or stop squamous cell head and neck cancers, a University of Michigan study found. http://medicalxpress.com/news/2012-10-common-food-tumor-growth.html Cancer Wed, 31 Oct 2012 19:10:13 EST news270929405 (Medical Xpress)—Physicians are less likely to trust the results of clinical trials when they know those trials were funded by pharmaceutical companies, regardless of the quality of the research, a recent study in the New England Journal of Medicine shows. http://medicalxpress.com/news/2012-10-physicians-drugs-pharmaceutical-industry-funded-trials.html Medications Tue, 09 Oct 2012 09:35:13 EST news268994102 Bringing life-like detail to a hospital near you: the 3-D mammogram, which doctors say is detecting breast cancer earlier and more accurately than traditional tests. http://medicalxpress.com/news/2012-10-d-mammograms-clearer-view-breast.html Cancer Sun, 07 Oct 2012 16:20:01 EST news268838168 If applied to the $5-billion-per-year dietary supplement industry, "quality by design" (QbD)—a mindset that helped revolutionize the manufacture of cars and hundreds of other products—could ease concerns about the safety and integrity of the herbal products used by 80 percent of the world's population. That's the conclusion of an article in ACS' Journal of Natural Products. http://medicalxpress.com/news/2012-10-high-quality-dietary-supplements-quality-by-design.html Medications Wed, 03 Oct 2012 16:22:01 EST news268500061 (AP)—The U.S. Food and Drug Administration says it has approved a first-of-a-kind heart-zapping implant from Boston Scientific that that does not directly touch the heart. http://medicalxpress.com/news/2012-09-less-invasive-heart-defibrillator.html Cardiology Sat, 29 Sep 2012 05:10:14 EST news268113323 Dr. Anglea Wandinger-Ness and Dr. Laurie Hudson were awarded a Provocative Questions grant to investigate the use of R-ketorolac against ovarian cancer. Ketorolac is an NSAID that the FDA approved for human use in 1991. They are investigating their hypothesis that R-ketorolac, and not S-ketorolac, acts on GTPases in the cell to control cell adhesion and growth in ovarian cancer cells. http://medicalxpress.com/news/2012-09-drug.html Medications Thu, 27 Sep 2012 13:44:25 EST news267972257 In research studies, scientists regularly use positron emission tomography (PET) scans to detect signs of Alzheimer's disease. Now, Washington University physicians at Barnes-Jewish Hospital are the first in Missouri to offer a new type of PET scan for patients with memory disorders and other forms of cognitive impairment who are not involved in research studies. http://medicalxpress.com/news/2012-08-imaging-aids-alzheimer-diagnosis.html Alzheimer's disease & dementia Thu, 23 Aug 2012 11:00:01 EST news264937351 Thirty years into the HIV epidemic, many people who are at high risk of HIV infection cannot or will not adopt safer sexual practices, such as abstinence and condom use. This means there is room in the market for alternative methods to reduce either exposure to or transmission of HIV among these individuals. One such strategy, HIV home testing (HT), is the subject of a recent study by Alex Carballo-Dieguez and his colleagues at the HIV Center for Clinical and Behavioral Studies at New York. Their work appears online in the journal AIDS and Behavior. http://medicalxpress.com/news/2012-08-hiv-home-kits-worth.html HIV & AIDS Mon, 20 Aug 2012 12:56:21 EST news264686109 Imagine millions of cancer cells organized in thousands of small divots. Hit these cells with drugs and when some cells die, you have a candidate for a cancer drug. But a review published this week in the journal Expert Opinion on Drug Discovery argues that these 2D models in fact offer very little information about a potential drug's effects in the body and may often give researchers misleading results. http://medicalxpress.com/news/2012-07-d-tumor-drug-discovery-success.html Medications Fri, 20 Jul 2012 10:06:09 EST news261997557 (HealthDay) -- Non-nutritive sweeteners like Splenda, Equal and Sweet'N Low may have a role to play in maintaining or even losing weight, as long as people don't use them as an excuse to treat themselves later with high-calorie goodies. http://medicalxpress.com/news/2012-07-major-medical-groups-sweeteners-diet.html Health Mon, 09 Jul 2012 19:50:02 EST news261074811 For many, it's a medical conundrum: The very pacemaker keeping their heart in rhythm prevents them from undergoing an MRI to diagnose other ailments, because interaction between the two devices could prove deadly. http://medicalxpress.com/news/2012-05-device-pacemaker-patients-safely-mris.html Cardiology Fri, 25 May 2012 12:50:01 EST news257159891 The Food and Drug Administration has approved a new test to help physicians diagnose a group of rare cell disorders. The test, or assay, was developed by an expert at Virginia Commonwealth University in the field of mast cells. http://medicalxpress.com/news/2012-05-fda-mastocytosis-diagnosis.html Medical research Tue, 22 May 2012 12:54:10 EST news256910040 (AP) -- A pill to prevent HIV infection is already being given to some healthy people, but without government approval, it remains out of reach and too costly for many who need it. http://medicalxpress.com/news/2012-05-advocates-hiv-pill.html HIV & AIDS Fri, 11 May 2012 11:59:29 EST news255956363 (HealthDay) -- U.S. health officials announced Tuesday that birth controls pills containing drospirenone -- a man-made version of the hormone progesterone -- may be associated with a higher risk of blood clots and will require new labels. http://medicalxpress.com/news/2012-04-birth-pills-higher-blood-clot.html Medications Tue, 10 Apr 2012 16:47:51 EST news253295261 The Cardiovascular Research Foundation (CRF) today announced the initiation of the HORIZONS-AMI II randomized trial, evaluating Promus Element platinum-chromium everolimus-eluting stents versus Omega bare-metal stents in patients with heart attack undergoing primary angioplasty with bivalirudin anticoagulation. The HORIZONS-AMI II trial will also investigate the chronic use of the antiplatelet medications prasugrel versus clopidogrel in patients free of major events at 30 days. http://medicalxpress.com/news/2012-03-cardiovascular-foundation-horizons-ami-ii-clinical.html Cardiology Tue, 27 Mar 2012 09:58:18 EST news252060971 Antidepressants can play a key role in alleviating painful conditions like osteoarthritis and may result in fewer side effects than traditionally prescribed drug regimes, such as anti-inflammatories and opioids, according to a perspective paper published online ahead of print publication by the International Journal of Clinical Practice. http://medicalxpress.com/news/2012-03-antidepressant-effective-alleviating-osteoarthritis-pain.html Arthritis & Rheumatism Thu, 22 Mar 2012 09:28:32 EST news251627300 US health authorities on Tuesday issued a warning to the maker of a new inhalable caffeine product sold in the United States and France, citing mislabeling and safety concerns. http://medicalxpress.com/news/2012-03-health-authorities-inhalable-caffeine.html Health Tue, 06 Mar 2012 16:51:02 EST news250275053 After a decade and a half of near stagnation, four new drugs could help make advanced prostate cancer a chronic illness instead of a terminal disease, a leading Colorado prostate cancer expert says. http://medicalxpress.com/news/2012-02-drugs-prostate-cancer.html Cancer Thu, 16 Feb 2012 14:11:39 EST news248623872 A new skin cancer drug tested for the first time in the world five years ago at the Virginia G. Piper Cancer Center at Scottsdale Healthcare just received expedited approval by the U.S. Food and Drug Administration, a remarkable accomplishment in new drug development. http://medicalxpress.com/news/2012-02-fda-skin-cancer-drug.html Cancer Wed, 01 Feb 2012 13:13:19 EST news247324388 US officials sought a "groundbreaking" injunction against Indian drug giant Ranbaxy on Wednesday, saying the maker of the first generic version of cholesterol-lowering Lipitor has failed to meet US safety guidelines. http://medicalxpress.com/news/2012-01-injunction-indian-drug-firm-ranbaxy.html Medications Thu, 26 Jan 2012 04:26:32 EST news246774363 A quarter-century after the U.S. Food and Drug Administration approved the first prescription drugs based on the main psychoactive ingredient in marijuana, additional medicines derived from or inspired by the cannabis plant itself could soon be making their way to pharmacy shelves, according to drug companies, small biotech firms and university scientists. http://medicalxpress.com/news/2012-01-pot-based-prescription-drug-fda.html Medications Mon, 23 Jan 2012 04:05:13 EST news246513892 The University of Kentucky will be the first site in the state and one of a select few in the entire country participating in the first stages of a groundbreaking study to investigate the effects of MultiStem, a human adult stem cell product, on patients with acute ischemic stroke. The phase II clinical trial, known as Atherys stroke protocol B01-02, was recently approved by UK's institutional review board. http://medicalxpress.com/news/2012-01-university-kentucky-stem-cell-trial.html Medical research Fri, 13 Jan 2012 11:40:01 EST news245676554